Emerging clinical evidence supporting an immunomodulatory effect The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice has increased as the multisystem benefits of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback